Careers  |  Sign In  |  Register

Latest in Oncology

Over the last 30 years, cases of melanoma have increased from 11.2 to 22.7 cases per 100,000 people, according to a CDC report published on CBS. The rate of melanoma diagnoses, of which 90% are caused by UV rays, has been increasing while other cancer rates are declining. The CDC recommends using sunscreen...
In a new study according to The New York Times, researchers have proposed that the immune strengthening compounds and antibodies present in breast milk might explain an association was found between a lower risk of leukemia in children who were breastfed for at least 6 months. In the study from JAMA...
According to Reuters, Ibrance, a breast cancer drug from Pfizer is currently in Phase III clinical trials of a new drug. The drug is designed to treat the most common type of breast cancer, estrogen-receptor positive, human epidermal growth factor receptor 2-negative. Ibrance has been shown to increase the...